Dong Wu Selected Research

berbamine (penduline)

5/2007	Berbamine selectively induces apoptosis of human acute promyelocytic leukemia cells via survivin-mediated pathway.
1/2006	Berbamine: a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity.
1/2006	[Effects of berbamine on growth of leukemia cell line NB4 and its mechanism].
6/2005	[Effects of berbamine on K562 cells and its mechanisms in vitro and in vivo].
1/2003	[Detection of P-170 and treatment with berbamine in primary acute leukemia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dong Wu Research Topics

Disease

55	Neoplasms (Cancer) 06/2022 - 06/2005
20	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2007
15	Inflammation (Inflammations) 01/2022 - 09/2015
12	Neoplasm Metastasis (Metastasis) 02/2022 - 03/2013
12	Infections 01/2022 - 03/2004
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 11/2013
9	Pancreatitis 01/2022 - 09/2017
8	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2018
8	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2016
8	Asthma (Bronchial Asthma) 01/2021 - 10/2004
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2006
6	Cholangiocarcinoma 08/2022 - 11/2012
6	Fibrosis (Cirrhosis) 10/2021 - 04/2015
6	Body Weight (Weight, Body) 01/2019 - 07/2015
5	COVID-19 02/2021 - 01/2020
5	Leukemia 02/2013 - 01/2003
4	Multiple Myeloma 01/2021 - 08/2017
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2013
3	Liver Failure 12/2022 - 01/2013
3	Disease Progression 04/2022 - 01/2014
3	Reperfusion Injury 04/2021 - 01/2013
3	Colonic Neoplasms (Colon Cancer) 09/2019 - 02/2013
3	Insulin Resistance 01/2019 - 05/2017
3	Lymphatic Metastasis 01/2015 - 04/2011
2	Residual Neoplasm 02/2022 - 11/2013
2	Adenocarcinoma 02/2022 - 12/2021
2	Hypoxia (Hypoxemia) 01/2022 - 01/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2011
2	Ischemia 05/2021 - 01/2013
2	Carcinogenesis 01/2021 - 03/2017
2	Primitive Neuroectodermal Tumors (PNET) 01/2021 - 07/2019
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 07/2019
2	Ulcerative Colitis 01/2020 - 01/2017
2	Wounds and Injuries (Trauma) 01/2020 - 01/2013
2	Anemia 12/2019 - 03/2013
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 10/2019 - 02/2013
2	Chromosome Duplication 07/2019 - 08/2018
2	Weight Loss (Weight Reduction) 05/2019 - 01/2019
2	Diabetic Cardiomyopathies 05/2019 - 11/2018

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 02/2021 - 03/2004
11	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2012
9	Decitabine FDA Link 10/2017 - 11/2013
8	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2014
8	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2017
7	Biological ProductsIBA 01/2022 - 04/2016
6	EnzymesIBA 02/2022 - 05/2009
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
6	Sirtuin 1IBA 06/2021 - 09/2018
5	Messenger RNA (mRNA)IBA 02/2022 - 02/2013
5	CytokinesIBA 10/2021 - 03/2010
5	berbamine (penduline)IBA 05/2007 - 01/2003
4	lenvatinibIBA 04/2022 - 03/2021
4	Capsules (Microcapsules)IBA 01/2022 - 05/2015
4	AntioxidantsIBA 01/2022 - 01/2014
4	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 12/2016
4	salicylhydroxamic acid (SHAM)IBA 05/2019 - 05/2017
3	CollagenIBA 03/2022 - 01/2018
3	AntibodiesIBA 03/2021 - 12/2020
3	TitaniumIBA 01/2021 - 01/2015
3	Antiphospholipid AntibodiesIBA 12/2020 - 01/2020
3	sulforaphaneIBA 09/2019 - 02/2013
3	Hormones (Hormone)IBA 07/2019 - 09/2018
3	MicroRNAs (MicroRNA)IBA 01/2019 - 02/2015
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 05/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2018 - 01/2012
3	AntigensIBA 01/2018 - 01/2014
3	Fetal Proteins (Fetoprotein)IBA 04/2016 - 11/2012
3	Interleukin-13IBA 03/2016 - 10/2004
2	Antiviral Agents (Antivirals)IBA 02/2022 - 01/2018
2	N-methyladenosineIBA 01/2022 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2022 - 04/2011
2	Long Noncoding RNAIBA 01/2022 - 08/2018
2	myricetinIBA 06/2021 - 12/2020
2	Interleukin-6 (Interleukin 6)IBA 02/2021 - 01/2020
2	PhytochemicalsIBA 02/2021 - 08/2016
2	AlbuminsIBA 02/2021 - 08/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2020
2	Proton Pump InhibitorsIBA 01/2021 - 11/2018
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2011
2	Prothrombin (Factor II)IBA 12/2020 - 01/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020 - 11/2018
2	AcidsIBA 10/2020 - 12/2019
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 08/2019
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2015
2	LipidsIBA 05/2019 - 01/2019
2	GhrelinIBA 01/2019 - 05/2017
2	Insulin (Novolin)FDA Link 09/2018 - 05/2017
2	VimentinIBA 05/2018 - 01/2018
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 02/2013

Therapy/Procedure

26	Therapeutics 08/2022 - 04/2008
10	Hepatectomy 12/2022 - 11/2012
7	Drug Therapy (Chemotherapy) 02/2022 - 06/2015
4	Aftercare (After-Treatment) 04/2022 - 06/2005
4	Radiotherapy 02/2022 - 06/2015
3	Immunotherapy 04/2022 - 01/2021
3	Adjuvant Chemotherapy 01/2022 - 01/2021
3	Length of Stay 01/2021 - 10/2016
3	Bariatric Surgery 11/2018 - 05/2017
2	Gastrectomy 01/2022 - 01/2022
2	Lasers (Laser) 05/2021 - 11/2018